We've all heard it: The 30-second spot is dying, with penny-pinching procurement practices driving the final nail in its coffin. But some interesting new data on the over-the-counter drug category -- the biggest adopter of the 15-second spot over the longer version -- might just argue for its revival.
Killing Off 30-second Spot Is Bad Medicine for OTC Drug Industry
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.